首页 > YB1论文

Genetically modified “obligate” anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma
基因编辑的“专性”厌氧沙门氏菌YB1作为神经母细胞瘤的治疗策略

论文出处：Journal of Hematology & Oncology

发表时间：2015

Source：Journal of Hematology & Oncology

Published：2015

【查看 PDF】

上一篇：IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella
IFN-γ依赖性NK细胞的激活对工程沙门氏菌抑制转移至关重要?
下一篇：Explicit hypoxia targeting with tumor suppression by creating an “obligate”anaerobic Salmonella Typhimurium strain
通过创建“专性”厌氧沙门氏菌菌株YB1明确靶向肿瘤低氧区和抑制肿瘤生长

网址：www.yb1bio.com

邮箱：info@yb1bio.com

公司地址：深圳市福田区深南大道2007号金地中心8层
8 / F, Jindi center, 2007 Shennan Avenue, Futian District, Shenzhen

@2011-2021 港药溶瘤生物制药有限公司 HKND YB1 PHARMACEUTICAL LIMITED
粤ICP备2021121218号-1